Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | GALR3 | O60755 | 1/20 | 0.45 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.45 |
| ▸ | GPR183 | P32249 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 5/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Flurpiridaz F 18 SCHEMBL12453262 | 1.00 | SMN1; SMN2 (0.45) | SMN1; SMN2LMNANPC1RAB9AMEN1 | |
| SCHEMBL22249092 | 0.97 | SMN1; SMN2 (0.43) | SMN1; SMN2LMNANPC1RAB9AMEN1 | |
| SCHEMBL15566349 | 0.91 | SMN1; SMN2 (0.49) | SMN1; SMN2LMNANPC1RAB9AMEN1 | |
| Flurpiridaz SCHEMBL16901966 | 0.91 | SMN1; SMN2 (0.42) | SMN1; SMN2LMNANPC1RAB9AMEN1 | |
| SCHEMBL15596646 | 0.91 | SMN1; SMN2 (0.42) | SMN1; SMN2LMNANPC1RAB9AMEN1 | |
| SCHEMBL1629038 | 0.91 | SMN1; SMN2 (0.45) | SMN1; SMN2LMNANPC1RAB9AMEN1 | |
| SCHEMBL18672268 | 0.91 | SMN1; SMN2 (0.46) | SMN1; SMN2LMNANPC1RAB9AMEN1 | |
| SCHEMBL15596698 | 0.91 | APP (0.48) | SMN1; SMN2LMNANPC1RAB9AMEN1 | |
| SCHEMBL16998559 | 0.91 | SMN1; SMN2 (0.41) | SMN1; SMN2LMNANPC1RAB9AMEN1 | |
| SCHEMBL15565441 | 0.91 | SMN1; SMN2 (0.41) | SMN1; SMN2LMNANPC1RAB9AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260124326-A1 | USE OF CYCLODEXTRINS AS A RADIOSTABILIZER | GE HEALTHCARE LTD (GB) | 2026-05-07 | — | — | US | claimed |
| US-12527884-B2 | Use of cyclodextrins as a radiostabilizer | GE HEALTHCARE LIMITED (GB) | 2026-01-20 | — | — | US | claimed |
| WO-2025226286-A1 | SYSTEMS AND METHODS FOR SIMULTANEOUS IMAGING OF MULTIPLE POSITRON EMISSION TOMOGRAPHY (PET) TRACERS | MULTIF UNCTIONAL IMAGING LLC (US) | 2025-10-30 | — | — | WO | claimed |
| US-20250329024-A1 | SYSTEMS AND METHODS FOR SIMULTANEOUS IMAGING OF MULTIPLE POSITRON EMISSION TOMOGRAPHY (PET) TRACERS | MultiFunctional Imaging LLC (US) | 2025-10-23 | — | — | US | claimed |
| US-20250312494-A1 | METHOD FOR PREPARING AN [18F] RADIOLABELLED COMPOUND WITH LOW WATER CONTENT DURING LABELLING STEP | GE HEALTHCARE INC (GB) | 2025-10-09 | — | — | US | claimed |
| US-20250312782-A1 | APPARATUS AND METHOD FOR SOLID PHASE EXTRACTION | GE HEALTHCARE LTD (GB) | 2025-10-09 | — | — | US | claimed |
| EP-4330662-B1 | ANALYTICAL HPLC | GE HEALTHCARE LTD (GB) | 2025-09-03 | — | — | EP | claimed |
| US-20250232865-A1 | SYSTEMS AND METHODS FOR IMAGE REGISTRATION | GE Precision Healthcare LLC | 2025-07-17 | — | — | US | claimed |
| EP-4585155-A1 | SYSTEMS AND METHODS FOR IMAGE REGISTRATION | GE Precision Healthcare LLC (US) | 2025-07-16 | — | — | EP | claimed |
| CN-114555133-B | Use of cyclodextrins as radiostabilizers | 通用电气健康护理有限公司 | 2025-02-11 | — | — | CN | claimed |
| EP-4355715-A1 | METHOD FOR PREPARING AN [18F] RADIOLABELLED COMPOUND WITH LOW WATER CONTENT DURING LABELLING STEP | GE Healthcare Limited (GB) | 2024-04-24 | — | — | EP | claimed |
| EP-4330662-A1 | ANALYTICAL HPLC | GE Healthcare Limited (GB) | 2024-03-06 | — | — | EP | claimed |
| CN-117500773-A | Method for preparing [18F ] radiolabelled compounds with low water content during the labelling step | 通用电气健康护理有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-117222890-A | Analytical HPLC | 通用电气健康护理有限公司 | 2023-12-12 | — | — | CN | claimed |
| US-20220409752-A1 | USE OF CYCLODEXTRINS AS A RADIOSTABILIZER | GE HEALTHCARE LIMITED (GB) | 2022-12-29 | — | — | US | claimed |
| WO-2022263594-A1 | METHOD FOR PREPARING AN [18F] RADIOLABELLED COMPOUND WITH LOW WATER CONTENT DURING LABELLING STEP | GE HEALTHCARE LIMITED (GB) | 2022-12-22 | — | — | WO | claimed |
| WO-2022263592-A1 | PREPARATION OF A PH-ADJUSTED ASCORBIC ACID SOLUTION | GE HEALTHCARE LIMITED (GB) | 2022-12-22 | — | — | WO | claimed |
| WO-2022229155-A1 | ANALYTICAL HPLC | GE HEALTHCARE LIMITED (GB) | 2022-11-03 | — | — | WO | claimed |
| EP-4048323-A1 | USE OF CYCLODEXTRINS AS A RADIOSTABILIZER | GE Healthcare Limited (GB) | 2022-08-31 | — | — | EP | claimed |
| CN-114555133-A | Use of cyclodextrins as radiostabilizers | 通用电气健康护理有限公司 | 2022-05-27 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124326-A1 | USE OF CYCLODEXTRINS AS A RADIOSTABILIZER | SLC7A11, BTD, PGD | SMN1; SMN2 4284/4885LMNA 3314/4885NPC1 1535/4885 |
| US-20220409752-A1 | USE OF CYCLODEXTRINS AS A RADIOSTABILIZER | SLC7A11, TBCA, GYPA | SMN1; SMN2 4640/4885LMNA 3471/4885NPC1 3012/4885 |
| US-20250312494-A1 | METHOD FOR PREPARING AN [18F] RADIOLABELLED COMPOUND WITH LOW WATER CONTENT DURING LABELLING STEP | AQP1, AQP3, TMEM14C | SMN1; SMN2 4660/4885LMNA 2637/4885NPC1 322/4885 |
| US-12527884-B2 | Use of cyclodextrins as a radiostabilizer | BTD, SLC7A11, PGD | SMN1; SMN2 4542/4885LMNA 3667/4885NPC1 1459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.